Liver disease



COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response


The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.

liver outline in human body_AS

Early identification and referral of liver disease in infants


This Guidelines summary is based on guidance included within the Children’s Liver Disease Foundation Yellow Alert Pack, written to provide general guidelines on the early identification of liver disease in infants and their referral where appropriate. 

Tick-boxes being ticked in IPB Green

CLDF guideline: Yellow Alert stool chart


A summary of the CLDF's Yellow Alert stool chart—for tracking the colour of newborn babies' stools and being alert to warning signs of prolonged jaundice.

Syringe with blood in IPB Green

BSG liver blood tests guideline


This summary covers the key points for GPs to consider when interpreting results from liver blood tests and how to respond to detected abnormalities.

liver outline in human body_AS

NICE non-alcoholic fatty liver disease guideline


A summary of NICE guidance on non-alcoholic fatty liver disease. Includes identification, lifestyle advice, and pharmacological treatment.

Educational resources

Webinar banner 3x22

Non-alcoholic steatohepatitis: identification, management, and referral pathways

Commissioned by Intercept Pharma UK and Ireland Ltd

The content on this page is intended for UK healthcare professionals only.